Depression and Anxiety Trial, Recruiting NCT07602374 Sponsor: University of California, San Francisco Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07602374
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People attending the UCSF plastic surgery breast reconstruction clinic for the first time (not a return visit)
  • People considering mastectomy (breast removal surgery) because of a breast cancer diagnosis
  • People considering mastectomy as a preventive measure because of a confirmed high-risk gene variant
  • People considering a staged surgical plan, such as a delayed mastectomy combined with an initial breast reduction
  • People who have not yet decided between a lumpectomy (partial breast removal) and a mastectomy

Who may not be able to join:

  • People who are returning patients already attending the clinic for follow-up appointments
  • People who are mainly considering a lumpectomy or oncoplastic reduction (a type of breast-reshaping surgery) at the time of their visit
  • People who do not speak English, as the educational materials used in this trial are currently only available in English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Merisa Piper, MD, University of California, San Francisco

Phone: 877-827-3222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 June 2026
Est. completion
31 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean scores on the Spielberger State-Trait Anxiety Inventory (STAI), State Form; Mean scores on the Preparation for Decision Making (PrepDM) Scale -; Mean scores on Reconstruction-Specific Knowledge Quiz

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov